Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Suicide Prevention
  • Hospital Charity Care
  • Hantavirus
  • TrumpRx
  • Pharmacy Discount Coupons

WHAT'S NEW

  • Suicide Prevention
  • Hospital Charity Care
  • Hantavirus
  • TrumpRx
  • Pharmacy Discount Coupons

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Jul 27 2022

Full Issue

Perspectives: More Focus Needed On Antibiotic Resistance; The Risks Of Criminalizing Meds

Read recent commentaries about drug-cost issues.

The Washington Post: Antibiotic Resistance Must Be Reprioritized As Superbugs Rise

Antibiotic resistance is a global public health crisis, a shadow pandemic. It threatens the effectiveness of medicines that are vital for surgery, chemotherapy, organ transplants and other procedures. It has been known for decades that bacteria evolve to resist antibiotics, and that overuse in human health and animal agriculture have contributed to the worsening situation. Some bacteria have become “superbugs” resistant to several types of antibiotics. (7/25)

The New York Times: We Know What Happens When Medicine Is Criminalized

Under Roe, most obstetricians and gynecologists didn’t face this level of legal peril. But this isn’t the first time America has criminalized aspects of medicine. Physicians who prescribe controlled substances like opioids carry a similar burden. (Maia Szalavitz, 7/26)

Newsweek: FDA-Induced Shortages Are Nothing New

FDA asked drug companies to gather new data on old drugs, some of which had been used for hundreds of years, and take them through the FDA approval process. In exchange, FDA would outlaw any other drug manufacturer from making and selling that drug—granting complete monopoly power to that company. (Brian Harrison and James R. Lawrence, III, 7/22)

New England Journal of Medicine: Pembrolizumab In The Treatment Of Breast Cancer 

In this issue of the Journal, Cortes et al.1 report that pembrolizumab — a breakthrough therapeutic treatment for patients with advanced triple-negative breast cancer — combined with chemotherapy prolonged overall survival among these patients. (Xavier Pivot, M.D., Ph.D., 7/21)

San Francisco Chronicle: Why Is S.F.’s Drug Crisis So Out Of Control? Stop Blaming Chesa And Look At Walgreens

According to a lawsuit filed by the City Attorney’s Office, for more than a decade, Walgreens was the largest distributor of opioids in San Francisco — and was a key player in setting off the current iteration of our crisis. The suit claims Walgreens irresponsibly distributed prescription opioids to San Franciscans, contributing to a rise in fatal overdoses, addiction and public drug use. (Nuala Bishari, 7/23)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, May 12
  • Monday, May 11
  • Friday, May 8
  • Thursday, May 7
  • Wednesday, May 6
  • Tuesday, May 5
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF